Ginkgo Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Ginkgo General Information

Description

Developer of anti-virus drug development and commercialization designed for growing products. The company offers modular lab automation, automation control software, high-throughput screening, next-generation sequencing library preparation, and adaptive laboratory evolution, enabling biopharmaceutical and agricultural organizations to accelerate research and development cycles.

Contact Information

Website
www.ginkgopharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C11-301
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215000
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • C11-301
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215000
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ginkgo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 15-Jun-2026 Completed Generating Revenue
6. Secondary Transaction - Private 08-Jan-2024 Completed Generating Revenue
5. Later Stage VC (Series B) 21-Jun-2017 Completed Generating Revenue
4. Later Stage VC 10-Apr-2017 Completed Generating Revenue
3. Later Stage VC (Series A) 10-Dec-2015 Completed Generating Revenue
2. Secondary Transaction - Private 03-Aug-2015 $802K Completed Generating Revenue
1. Corporate 18-Feb-2013 $802K $802K Completed Generating Revenue
To view Ginkgo’s complete valuation and funding history, request access »

Ginkgo Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of anti-virus drug development and commercialization designed for growing products. The company offers modular
Drug Discovery
Suzhou, China

Boston, MA
 

Emeryville, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ginkgo Competitors (2)

One of Ginkgo’s 2 competitors is Ginkgo Bioworks, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ginkgo Bioworks Formerly VC-backed Boston, MA
Amyris (Biotechnology) Private Equity-Backed Emeryville, CA
You’re viewing 2 of 2 competitors. Get the full list »

Ginkgo Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Ginkgo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019141179-A1 Pyridone derivative, composition thereof and application thereof as anti-influenza drug Inactive 17-Jan-2018
AU-2017304952-A1 Isoquinolinone compound and use thereof in preparation of antiviral drugs Inactive 29-Jul-2016
EP-3492467-A1 Isoquinolinone compound and use thereof in preparation of antiviral drugs Inactive 29-Jul-2016
EP-3492467-A4 Isoquinolinone compound and use thereof in preparation of antiviral drugs Inactive 29-Jul-2016
WO-2018019297-A1 Isoquinolinone compound and use thereof in preparation of antiviral drugs Inactive 29-Jul-2016 A61K31/4375
To view Ginkgo’s complete patent history, request access »

Ginkgo Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cowin Capital Venture Capital Minority
Kaitai Capital Venture Capital Minority
Shiyu Capital Venture Capital Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
Jameho Investment PE/Buyout Minority
You’re viewing 5 of 7 investors. Get the full list »

Ginkgo Investments & Acquisitions (2)

Ginkgo’s most recent deal was a PE Growth/Expansion with Optiréno for . The deal was made on 04-Apr-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Optiréno 04-Apr-2017 PE Growth/Expansion Construction and Engineering
Motif FoodWorks Merger/Acquisition Food Products
To view Ginkgo’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Ginkgo Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Motif FoodWorks Boston, MA 2018

Ginkgo FAQs

  • When was Ginkgo founded?

    Ginkgo was founded in 2009.

  • Where is Ginkgo headquartered?

    Ginkgo is headquartered in Suzhou, China.

  • What industry is Ginkgo in?

    Ginkgo’s primary industry is Drug Discovery.

  • Is Ginkgo a private or public company?

    Ginkgo is a Private company.

  • What is Ginkgo’s current revenue?

    The current revenue for Ginkgo is .

  • How much funding has Ginkgo raised over time?

    Ginkgo has raised $20.8M.

  • Who are Ginkgo’s investors?

    Cowin Capital, Kaitai Capital, Shiyu Capital, LAV (Lilly Asia Fund), and Jameho Investment are 5 of 7 investors who have invested in Ginkgo.

  • Who are Ginkgo’s competitors?

    Ginkgo Bioworks and Amyris (Biotechnology) are competitors of Ginkgo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process